• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

地塞米松抑制试验中皮质醇不被抑制与慢性精神分裂症患者原发性烦渴的关系

Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia.

作者信息

Goldman M B, Blake L, Marks R C, Hedeker D, Luchins D J

机构信息

Department of Psychiatry, University of Chicago, IL 60637.

出版信息

Am J Psychiatry. 1993 Apr;150(4):653-5. doi: 10.1176/ajp.150.4.653.

DOI:10.1176/ajp.150.4.653
PMID:8465887
Abstract

Thirteen polydipsic and 40 nonpolydipsic chronic schizophrenic patients received the dexamethasone suppression test while stabilized on psychotropic medication regimens. Thirty-eight percent (N = 5) of those with polydipsia but only 5% (N = 2) of those without polydipsia were nonsuppressors of cortisol (i.e., had an abnormal response). It is suggested that hippocampal dysfunction could cause both polydipsia and cortisol dysregulation in these patients.

摘要

13名有烦渴症状和40名无烦渴症状的慢性精神分裂症患者在稳定服用精神药物治疗方案期间接受了地塞米松抑制试验。有烦渴症状的患者中38%(N = 5)为皮质醇非抑制者(即反应异常),而无烦渴症状的患者中只有5%(N = 2)为皮质醇非抑制者。提示海马功能障碍可能导致这些患者出现烦渴和皮质醇调节异常。

相似文献

1
Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia.地塞米松抑制试验中皮质醇不被抑制与慢性精神分裂症患者原发性烦渴的关系
Am J Psychiatry. 1993 Apr;150(4):653-5. doi: 10.1176/ajp.150.4.653.
2
Diminished glucocorticoid negative feedback in polydipsic hyponatremic schizophrenic patients.
J Clin Endocrinol Metab. 2007 Feb;92(2):698-704. doi: 10.1210/jc.2006-1131. Epub 2006 Nov 21.
3
Platelet 5-HT and plasma cortisol concentrations after dexamethasone suppression test in patients with different time course of schizophrenia.
Neuropsychobiology. 1998;37(3):142-5. doi: 10.1159/000026493.
4
Dexamethasone suppression test in schizophrenia: its relation to monoamine metabolism in hypothalamic-pituitary-adrenal axis.
Neuropsychobiology. 1990;24(1):12-6. doi: 10.1159/000119036.
5
Dexamethasone suppression test in severe schizophrenic illness: effects of plasma dexamethasone and caffeine levels.
Acta Psychiatr Scand. 1987 Jun;75(6):608-13. doi: 10.1111/j.1600-0447.1987.tb02844.x.
6
The dexamethasone suppression test in residual schizophrenia with depression.
Am J Psychiatry. 1984 Feb;141(2):250-2. doi: 10.1176/ajp.141.2.250.
7
Dexamethasone nonsuppression in chronic schizophrenia.
Acta Psychiatr Scand. 1988 Jan;77(1):58-62. doi: 10.1111/j.1600-0447.1988.tb05077.x.
8
The incidence of abnormal dexamethasone suppression in schizophrenia: a review and a meta-analytic comparison with the incidence in normal controls.
Can J Psychiatry. 1990 Mar;35(2):128-32. doi: 10.1177/070674379003500204.
9
Neuroendocrine responses to a cold pressor stimulus in polydipsic hyponatremic and in matched schizophrenic patients.多饮性低钠血症患者及匹配的精神分裂症患者对冷加压刺激的神经内分泌反应。
Neuropsychopharmacology. 2007 Jul;32(7):1611-21. doi: 10.1038/sj.npp.1301282. Epub 2006 Dec 13.
10
Dexamethasone suppression test in first-episode schizophrenia.首发精神分裂症的地塞米松抑制试验
Neuro Endocrinol Lett. 2006 Aug;27(4):433-7.

引用本文的文献

1
Brain circuit dysfunction in a distinct subset of chronic psychotic patients.特定慢性精神病患者亚组中的脑回路功能障碍。
Schizophr Res. 2014 Aug;157(1-3):204-13. doi: 10.1016/j.schres.2014.06.001. Epub 2014 Jul 1.
2
Differences in the structure of drinking, cart expression and dopamine turnover between polydipsic and non polydipsic rats in the quinpirole model of psychotic polydipsia.精神病性烦渴喹吡罗模型中多饮和非多饮大鼠在饮水结构、cART表达及多巴胺代谢方面的差异。
Psychopharmacology (Berl). 2014 Oct;231(19):3889-97. doi: 10.1007/s00213-014-3527-0. Epub 2014 Mar 20.
3
Polydipsia-hyponatraemia syndrome : epidemiology, clinical features and treatment.
多饮-低钠血症综合征:流行病学、临床特征和治疗。
CNS Drugs. 1997 Feb;7(2):121-38. doi: 10.2165/00023210-199707020-00004.
4
Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.两种不同剂量鼻内催产素对伴有和不伴有多饮的精神分裂症患者面部表情识别的不同影响。
Psychopharmacology (Berl). 2011 Jul;216(1):101-10. doi: 10.1007/s00213-011-2193-8. Epub 2011 Feb 9.
5
Structural pathology underlying neuroendocrine dysfunction in schizophrenia.精神分裂症神经内分泌功能障碍的结构病理学。
Behav Brain Res. 2011 Mar 17;218(1):106-13. doi: 10.1016/j.bbr.2010.11.025. Epub 2010 Nov 17.
6
Disruption of the neuregulin 1 gene in the rat alters HPA axis activity and behavioral responses to environmental stimuli.神经调节蛋白 1 基因在大鼠中的破坏改变了 HPA 轴的活性和对环境刺激的行为反应。
Physiol Behav. 2011 Aug 3;104(2):205-14. doi: 10.1016/j.physbeh.2010.11.015. Epub 2010 Nov 16.
7
The mechanism of life-threatening water imbalance in schizophrenia and its relationship to the underlying psychiatric illness.精神分裂症中危及生命的水代谢失衡机制及其与潜在精神疾病的关系。
Brain Res Rev. 2009 Oct;61(2):210-20. doi: 10.1016/j.brainresrev.2009.06.004. Epub 2009 Jul 9.
8
A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.利培酮与奥氮平治疗抗精神病药致急性肌张力障碍或帕金森病的精神分裂症患者的随机对照研究。
J Psychopharmacol. 2010 Jan;24(1):91-8. doi: 10.1177/0269881108096070. Epub 2008 Sep 18.
9
Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.患有神经内分泌功能障碍和情绪缺陷的精神分裂症患者血浆催产素水平降低。
Schizophr Res. 2008 Jan;98(1-3):247-55. doi: 10.1016/j.schres.2007.09.019. Epub 2007 Oct 24.